Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Target: Identification for High Risk Childhood AML Based on Genome-Wide Analysis

NCT01076569 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01076569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01076569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Target: Identification for High Risk Childhood AML Based on Genome-Wide Analysis
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
March 31, 2010
Completion date
May 31, 2016
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

childhood acute basophilic leukemia, childhood acute eosinophilic leukemia, childhood acute erythroleukemia (m6), childhood acute megakaryocytic leukemia (m7), childhood acute minimally differentiated myeloid leukemia (m0), childhood acute monoblastic leukemia (m5a), childhood acute monocytic leukemia (m5b), childhood acute myeloblastic leukemia with maturation (m2), childhood acute myeloblastic leukemia without maturation (m1), childhood acute myelomonocytic leukemia (m4), recurrent childhood acute myeloid leukemia, untreated childhood acute myeloid leukemia and other myeloid malignancies